HK1167388A1 - Anticancer compound and pharmaceutical composition containing the same - Google Patents

Anticancer compound and pharmaceutical composition containing the same

Info

Publication number
HK1167388A1
HK1167388A1 HK12108002.5A HK12108002A HK1167388A1 HK 1167388 A1 HK1167388 A1 HK 1167388A1 HK 12108002 A HK12108002 A HK 12108002A HK 1167388 A1 HK1167388 A1 HK 1167388A1
Authority
HK
Hong Kong
Prior art keywords
compound
same
pharmaceutical composition
composition containing
anticancer compound
Prior art date
Application number
HK12108002.5A
Other languages
English (en)
Inventor
Jean-Christophe Carry
Michel Cheve
Francois Clerc
Cecile Combeau
Sylvie Gontier
Alain Krick
Sylvette Lachaud
Laurent Schio
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of HK1167388A1 publication Critical patent/HK1167388A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK12108002.5A 2009-05-18 2012-08-15 Anticancer compound and pharmaceutical composition containing the same HK1167388A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0902392A FR2945535B1 (fr) 2009-05-18 2009-05-18 Compose anticancereux et composition pharmaceutique le contenant
PCT/FR2010/050948 WO2010133794A1 (fr) 2009-05-18 2010-05-17 Compose anticancéreux et composition pharmaceutique le contenant

Publications (1)

Publication Number Publication Date
HK1167388A1 true HK1167388A1 (en) 2012-11-30

Family

ID=40973187

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12108002.5A HK1167388A1 (en) 2009-05-18 2012-08-15 Anticancer compound and pharmaceutical composition containing the same

Country Status (35)

Country Link
US (2) US9073917B2 (xx)
EP (1) EP2432766B1 (xx)
JP (1) JP5656981B2 (xx)
KR (1) KR20120032483A (xx)
CN (1) CN102459193B (xx)
AR (1) AR076686A1 (xx)
AU (1) AU2010251013B2 (xx)
BR (1) BRPI1012201A2 (xx)
CA (1) CA2762233C (xx)
CL (1) CL2011002930A1 (xx)
CO (1) CO6400138A2 (xx)
CY (1) CY1114850T1 (xx)
DK (1) DK2432766T3 (xx)
EA (1) EA021084B1 (xx)
ES (1) ES2430989T3 (xx)
FR (1) FR2945535B1 (xx)
HK (1) HK1167388A1 (xx)
HR (1) HRP20130959T1 (xx)
IL (1) IL216361A0 (xx)
JO (1) JO2852B1 (xx)
MA (1) MA33356B1 (xx)
ME (1) ME01542B (xx)
MX (1) MX2011012356A (xx)
MY (1) MY152995A (xx)
NZ (1) NZ596464A (xx)
PL (1) PL2432766T3 (xx)
PT (1) PT2432766E (xx)
RS (1) RS53002B (xx)
SG (1) SG176169A1 (xx)
SI (1) SI2432766T1 (xx)
SM (1) SMT201400005B (xx)
TW (1) TWI441822B (xx)
UY (1) UY32644A (xx)
WO (1) WO2010133794A1 (xx)
ZA (1) ZA201108447B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2945535B1 (fr) 2009-05-18 2011-06-10 Sanofi Aventis Compose anticancereux et composition pharmaceutique le contenant
FR2967413A1 (fr) * 2010-11-17 2012-05-18 Sanofi Aventis Compose 8-oxo-9-[3-(1h-benzimidazol-2-yloxy)-phenyl]-4,5,6,7,8,9-hexahydro-2h-pyrrolo[3,4-b]quinoline-3-carboxylate d'ethyle, sel, forme cristalline, co-cristal, formulation, procedes de preparation, application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteur des kinases aurora.
RS58700B1 (sr) 2012-10-12 2019-06-28 Broad Inst Inc Gsk3 inhibitori i postupci njihove primene
KR20170016987A (ko) 2014-07-01 2017-02-14 다케다 야쿠힌 고교 가부시키가이샤 헤테로시클릭 화합물 및 이들의 레티노이드-관련 희귀 수용체 (ｒｏｒ) 감마-ｔ 저해제로서의 용도
EA201992359A1 (ru) 2017-04-05 2020-03-12 Дзе Брод Инститьют Инк. Трициклические соединения в качестве ингибиторов киназы гликогенсинтазы-3 (gsk3) и их применение

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2391291A1 (en) 1999-11-19 2001-05-25 Abbott Laboratories Tricyclic dihydropyrimidine potassium channel openers
JP2005501800A (ja) 2001-02-02 2005-01-20 三菱ウェルファーマ株式会社 ジヒドロピラゾロピリジン化合物およびその医薬用途
US7037902B2 (en) 2002-07-03 2006-05-02 Receptron, Inc. Affinity small molecules for the EPO receptor
AU2004264834A1 (en) * 2003-06-13 2005-02-24 Zentaris Gmbh Compounds having inhibitive activity of phosphatidylinositol 3-kinase and methods of use thereof
SI1746097T1 (sl) 2005-07-20 2010-05-31 Aventis Pharma Sa dihidropiridin kondenzirani heterocikli postopek za njihovo pripravo njihova uporaba in sestavki ki jih vsebujejo
FR2945535B1 (fr) 2009-05-18 2011-06-10 Sanofi Aventis Compose anticancereux et composition pharmaceutique le contenant

Also Published As

Publication number Publication date
CY1114850T1 (el) 2016-12-14
ES2430989T3 (es) 2013-11-22
CA2762233A1 (fr) 2010-11-25
CN102459193A (zh) 2012-05-16
AU2010251013B2 (en) 2015-08-20
BRPI1012201A2 (pt) 2016-04-05
UY32644A (es) 2010-12-31
TW201100418A (en) 2011-01-01
PL2432766T3 (pl) 2013-12-31
HRP20130959T1 (hr) 2013-11-22
PT2432766E (pt) 2013-10-23
JP2012527436A (ja) 2012-11-08
NZ596464A (en) 2014-01-31
MX2011012356A (es) 2011-12-14
EP2432766B1 (fr) 2013-07-17
DK2432766T3 (da) 2013-10-28
SI2432766T1 (sl) 2013-11-29
JP5656981B2 (ja) 2015-01-21
EP2432766A1 (fr) 2012-03-28
SG176169A1 (en) 2011-12-29
ME01542B (me) 2014-04-20
US20120220621A1 (en) 2012-08-30
US20150266877A1 (en) 2015-09-24
IL216361A0 (en) 2012-01-31
ZA201108447B (en) 2013-01-30
AR076686A1 (es) 2011-06-29
FR2945535A1 (fr) 2010-11-19
FR2945535B1 (fr) 2011-06-10
EA021084B1 (ru) 2015-04-30
SMT201400005B (it) 2014-03-07
CN102459193B (zh) 2014-08-27
MA33356B1 (fr) 2012-06-01
AU2010251013A1 (en) 2011-12-08
TWI441822B (zh) 2014-06-21
EA201171429A1 (ru) 2012-05-30
US9073917B2 (en) 2015-07-07
CO6400138A2 (es) 2012-03-15
RS53002B (en) 2014-04-30
KR20120032483A (ko) 2012-04-05
CA2762233C (fr) 2017-11-28
CL2011002930A1 (es) 2012-06-29
US9221817B2 (en) 2015-12-29
JO2852B1 (en) 2015-03-15
WO2010133794A1 (fr) 2010-11-25
MY152995A (en) 2014-12-31

Similar Documents

Publication Publication Date Title
UA94052C2 (xx) Похідні піридазину$производные пиридазина
SG148178A1 (en) Indozolone derivatives as 11b-hsd1 inhibitors
MY143568A (en) 11b-hsd1 inhibitors for the treatment of diabetes
DE602006021539D1 (en) Morpholine als 5ht2c-agonisten
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
MX2011012627A (es) Derivados aminobutiricos sustituidos como inhibidores de nepralisina.
MY138941A (en) Aryl-pyridine derivatives
MX2010006799A (es) Benzofuropirimidinonas como inhibidores de la proteina cinasa.
EA018193B3 (ru) Соединения и фармацевтические композиции для снижения уровня мочевой кислоты
GEP20125459B (en) Compounds for inhibiting mitotic progression
MX2010005824A (es) Derivados de aminotiazol.
MY139522A (en) New alkyl-pyridines as 11-beta inhibitors for diabetes
IN2012DN03337A (xx)
TW200630364A (en) 2-amido-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
TW200740764A (en) Pyrazolone derivatives
MX2008016426A (es) Derivados de alquilpiridazina como inhibidores de 11 beta hidroxiesteroide deshidrogenasa tipo 1(11b-hsd 1).
HK1167388A1 (en) Anticancer compound and pharmaceutical composition containing the same
MX2009003169A (es) Derivados de sulfonamida.
MX2012007225A (es) Composicion farmaceutica que comprende mezcla de solventes y derivado o analogo de vitamina d.
IL191670A0 (en) Compounds for the inhibition of apoptosis
MX2009004295A (es) Uso de un acido indazolmetoxialcanoico para reducir niveles de triglicerido, colesterol y glucosa.
TNSN08242A1 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
TH135249A (th) สารประกอบตัวยับยั้งออโรราต้านมะเร็งและองค์ประกอบทางเภสัชกรรมที่มีสารดังกล่าว, กระบวนการและอินเทอร์มิเดียทสำหรับการเตรียมสารเหล่านั้น
EP1889831A3 (en) Diazenedicarboxamides as inhibitors of D-alanine: D-alanine ligase (Ddl)
MX2009013240A (es) Derivados de carboxamida heterociclicos, su uso farmaceutico y composiciones.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170517